Search Results - "Haisma, H.J."

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Targeted adenovirus mediated inhibition of NF-κB-dependent inflammatory gene expression in endothelial cells in vitro and in vivo by Kułdo, J.M., Ásgeirsdóttir, S.A., Zwiers, P.J., Bellu, A.R., Rots, M.G., Schalk, J.A.C., Ogawara, K.I., Trautwein, C., Banas, B., Haisma, H.J., Molema, G., Kamps, J.A.A.M.

    Published in Journal of controlled release (28-02-2013)
    “…In chronic inflammatory diseases the endothelium expresses mediators responsible for harmful leukocyte infiltration. We investigated whether targeted delivery…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors by Rots, M.G., Curiel, D.T., Gerritsen, W.R., Haisma, H.J.

    Published in Journal of controlled release (21-02-2003)
    “…Recombinant adenoviral vectors are promising reagents for therapeutic interventions in humans, including gene therapy for biologically complex diseases like…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX‐GA3 in combination with a monoclonal antibody β‐glucuronidase conjugate by Houba, P.H.J., Boven, E., van der Meulen‐Muileman, I.H., Leenders, R.G.G., Scheeren, J.W., Pinedo, H.M., Haisma, H.J.

    Published in International journal of cancer (15-02-2001)
    “…A glucuronide doxorubicin prodrug N‐[4‐doxorubicin‐N‐carbonyl (oxymethyl) phenyl] O‐β‐glucuronyl carbamate (DOX‐GA3) has been developed to improve the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Prostate specific membrane antigen (PSMA) is a tissue-specific target for adenoviral transduction of prostate cancer in vitro by Kraaij, R., van Rijswijk, A.L.C.T., Oomen, M.H.A., Haisma, H.J., Bangma, C.H.

    Published in The Prostate (15-02-2005)
    “…Background Adenovirus binds to the coxsackievirus and adenovirus receptor (CAR) as a first step in the process of cellular infection. This dependence on CAR…”
    Get full text
    Journal Article
  7. 7

    Highly efficient and carcinoma-specific adenoviral replication restricted by the EGP-2 promoter by Gommans, W.M., McLaughlin, P.M.J., Schalk, J.A.C., Groothuis, G.M.M., Haisma, H.J., Rots, M.G.

    Published in Journal of controlled release (22-01-2007)
    “…Although some successes have been reported using adenoviral vectors for the treatment of cancer, adenoviral cancer gene therapy is still hampered by the lack…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer by van der Poel, H G, Molenaar, B, van Beusechem, V W, Haisma, H J, Rodriguez, R, Curiel, D T, Gerritsen, W R

    Published in The Journal of urology (01-07-2002)
    “…We evaluated the delivery and oncolytic potential of targeted replication competent adenoviruses in bladder cancer lines. Seven established human bladder…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT) : Optimization of prodrug activating capacity by VINGERHOEDS, M. H, HAISMA, H. J, BELLIOT, S. O, SMIT, R. H. P, CROMMELIN, D. J. A, STORM, G

    Published in Pharmaceutical research (01-04-1996)
    “…Immuno-enzymosomes are tumor-specific immunoliposomes bearing enzymes on their surface. These enzymes are capable of converting relatively nontoxic prodrugs…”
    Get full text
    Journal Article
  14. 14

    One-year audit of admissions to the Intensive Care Unit of the Queen Elizabeth Central Hospital, Blantyre by Size, M., Borgstein, E.S. and Haisma, H.J.

    Published in Malawi medical journal (01-06-2005)
    “…The intensive care unit at Queen Elizabeth Central Hospital (QECH) has 4 beds and offers level 2 care. A retrospective audit of all admissions to the unit…”
    Get full text
    Journal Article
  15. 15

    Design of immuno-enzymosomes with maximum enzyme targeting capability: effect of the enzyme density on the enzyme targeting capability and cell binding properties by Fonseca, M.J., Haisma, H.J., Klaassen, S., Vingerhoeds, M.H., Storm, G.

    Published in Biochimica et biophysica acta (15-07-1999)
    “…Immuno-enzymosomes have been proposed for the targeting of enzymes to cancer cells to achieve site specific activation of anticancer prodrugs. Previously, we…”
    Get full text
    Journal Article
  16. 16

    A new application for liposomes in cancer therapy: Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs by Vingerhoeds, M.H., Haisma, H.J., van Muijen, M., van de Rijt, R.B.J., Crommelin, D.J.A., Storm, G.

    Published in FEBS letters (28-12-1993)
    “…We have tested a new type of immunoliposomes which may effectively mediate the targeting of enzymes to be used for site-specific prodrug activation…”
    Get full text
    Journal Article
  17. 17

    A new application for liposomes in cancer therapy by Vingerhoeds, M.H., Haisma, H.J., van Muijen, M., van de Rijt, R.B.J., Crommelin, D.J.A., Storm, G.

    Published in FEBS letters (28-12-1993)
    “…We have tested a new type of immunoliposomes which may effectively mediate the targeting of enzymes to be used for site‐specific prodrug activation…”
    Get full text
    Journal Article
  18. 18

    Distribution and pharmacokinetics of radiolabeled monoclonal antibody OC 125 after intravenous and intraperitoneal administration in gynecologic tumors by Haisma, H J, Moseley, K R, Battaile, A, Griffiths, T C, Knapp, R C

    “…Radiolabeled monoclonal antibodies may be useful for radioimmunotherapy of gynecologic tumors. Iodine 131-labeled F(ab')2 fragments of a monoclonal antibody,…”
    Get more information
    Journal Article
  19. 19

    Neuroleptic malignant syndrome by Haisma, H J, Constantinou, E, Chinyanga, H M

    Published in Central African journal of medicine (01-05-1990)
    “…While on holiday in Zimbabwe, a forty-one year old woman with a long history of intermittent psychiatric illness developed what was diagnosed as neuroleptic…”
    Get more information
    Journal Article
  20. 20

    Higher ADCC of murine peritoneal cells after immunization with allogenic tumor cells as compared with stimulation by adriamycin, BCG, and thioglycolate by Haisma, H J, Ligtenberg, M, Dullens, H F, Den Otter, W

    Published in Cellular immunology (01-09-1986)
    “…Normal peritoneal cells or spleen cells from C57BL mice could not lyse SRBC in an ADCC assay. After intraperitoneal injection of Adriamycin, BCG or…”
    Get more information
    Journal Article